US20090210036A1 - Laser ionization therapy system and method - Google Patents
Laser ionization therapy system and method Download PDFInfo
- Publication number
- US20090210036A1 US20090210036A1 US12/292,966 US29296608A US2009210036A1 US 20090210036 A1 US20090210036 A1 US 20090210036A1 US 29296608 A US29296608 A US 29296608A US 2009210036 A1 US2009210036 A1 US 2009210036A1
- Authority
- US
- United States
- Prior art keywords
- water
- detoxification method
- salt
- therapy
- patient
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 238000002560 therapeutic procedure Methods 0.000 title claims abstract description 36
- 238000000034 method Methods 0.000 title claims abstract description 31
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 55
- 150000002500 ions Chemical class 0.000 claims abstract description 40
- 238000001784 detoxification Methods 0.000 claims abstract description 28
- 230000001678 irradiating effect Effects 0.000 claims abstract description 8
- 235000002639 sodium chloride Nutrition 0.000 claims description 23
- 150000003839 salts Chemical class 0.000 claims description 19
- 239000000341 volatile oil Substances 0.000 claims description 15
- 230000001427 coherent effect Effects 0.000 claims description 8
- 240000000560 Citrus x paradisi Species 0.000 claims description 5
- 244000004281 Eucalyptus maculata Species 0.000 claims description 5
- 244000178870 Lavandula angustifolia Species 0.000 claims description 5
- 235000010663 Lavandula angustifolia Nutrition 0.000 claims description 5
- 239000001102 lavandula vera Substances 0.000 claims description 5
- 235000018219 lavender Nutrition 0.000 claims description 5
- 235000009024 Ceanothus sanguineus Nutrition 0.000 claims description 4
- 235000007866 Chamaemelum nobile Nutrition 0.000 claims description 4
- 235000008733 Citrus aurantifolia Nutrition 0.000 claims description 4
- 240000002319 Citrus sinensis Species 0.000 claims description 4
- 235000005976 Citrus sinensis Nutrition 0.000 claims description 4
- 240000004784 Cymbopogon citratus Species 0.000 claims description 4
- 235000017897 Cymbopogon citratus Nutrition 0.000 claims description 4
- 241000208152 Geranium Species 0.000 claims description 4
- 240000003553 Leptospermum scoparium Species 0.000 claims description 4
- 235000015459 Lycium barbarum Nutrition 0.000 claims description 4
- 244000042664 Matricaria chamomilla Species 0.000 claims description 4
- 235000007232 Matricaria chamomilla Nutrition 0.000 claims description 4
- 244000024873 Mentha crispa Species 0.000 claims description 4
- 235000014749 Mentha crispa Nutrition 0.000 claims description 4
- 244000179970 Monarda didyma Species 0.000 claims description 4
- 235000010672 Monarda didyma Nutrition 0.000 claims description 4
- 244000178231 Rosmarinus officinalis Species 0.000 claims description 4
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 4
- 235000011941 Tilia x europaea Nutrition 0.000 claims description 4
- 239000004571 lime Substances 0.000 claims description 4
- 239000011780 sodium chloride Substances 0.000 claims description 4
- 240000006909 Tilia x europaea Species 0.000 claims description 3
- 238000011282 treatment Methods 0.000 description 20
- 231100000765 toxin Toxicity 0.000 description 18
- 239000003053 toxin Substances 0.000 description 18
- 108700012359 toxins Proteins 0.000 description 18
- 210000003205 muscle Anatomy 0.000 description 10
- 210000005036 nerve Anatomy 0.000 description 9
- 239000000523 sample Substances 0.000 description 9
- 210000004185 liver Anatomy 0.000 description 8
- 230000008901 benefit Effects 0.000 description 7
- 238000012956 testing procedure Methods 0.000 description 7
- 229940079593 drug Drugs 0.000 description 6
- 239000003814 drug Substances 0.000 description 6
- 208000002193 Pain Diseases 0.000 description 5
- 230000001413 cellular effect Effects 0.000 description 5
- 229910052500 inorganic mineral Inorganic materials 0.000 description 5
- 239000007788 liquid Substances 0.000 description 5
- 235000010755 mineral Nutrition 0.000 description 5
- 239000011707 mineral Substances 0.000 description 5
- 230000036407 pain Effects 0.000 description 5
- 230000009286 beneficial effect Effects 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 3
- 210000000232 gallbladder Anatomy 0.000 description 3
- 230000035876 healing Effects 0.000 description 3
- 210000003734 kidney Anatomy 0.000 description 3
- 239000003921 oil Substances 0.000 description 3
- 239000002245 particle Substances 0.000 description 3
- 238000001126 phototherapy Methods 0.000 description 3
- 210000003296 saliva Anatomy 0.000 description 3
- 210000001541 thymus gland Anatomy 0.000 description 3
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- 208000036864 Attention deficit/hyperactivity disease Diseases 0.000 description 2
- 230000004543 DNA replication Effects 0.000 description 2
- 240000002989 Euphorbia neriifolia Species 0.000 description 2
- 206010020751 Hypersensitivity Diseases 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- 102100026459 POU domain, class 3, transcription factor 2 Human genes 0.000 description 2
- 101710133394 POU domain, class 3, transcription factor 2 Proteins 0.000 description 2
- MUMGGOZAMZWBJJ-DYKIIFRCSA-N Testostosterone Chemical compound O=C1CC[C@]2(C)[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 MUMGGOZAMZWBJJ-DYKIIFRCSA-N 0.000 description 2
- 241000700647 Variola virus Species 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 150000007513 acids Chemical class 0.000 description 2
- 230000007815 allergy Effects 0.000 description 2
- 239000012491 analyte Substances 0.000 description 2
- 238000009246 art therapy Methods 0.000 description 2
- 206010003246 arthritis Diseases 0.000 description 2
- 210000004556 brain Anatomy 0.000 description 2
- 238000009232 chiropractic Methods 0.000 description 2
- 239000006185 dispersion Substances 0.000 description 2
- 210000004907 gland Anatomy 0.000 description 2
- 238000002647 laser therapy Methods 0.000 description 2
- 210000004072 lung Anatomy 0.000 description 2
- 210000004324 lymphatic system Anatomy 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000003287 optical effect Effects 0.000 description 2
- 210000000056 organ Anatomy 0.000 description 2
- 244000045947 parasite Species 0.000 description 2
- 210000002307 prostate Anatomy 0.000 description 2
- 230000002040 relaxant effect Effects 0.000 description 2
- 210000000952 spleen Anatomy 0.000 description 2
- 230000008961 swelling Effects 0.000 description 2
- 239000008399 tap water Substances 0.000 description 2
- 235000020679 tap water Nutrition 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 208000004998 Abdominal Pain Diseases 0.000 description 1
- 244000144730 Amygdalus persica Species 0.000 description 1
- 208000006096 Attention Deficit Disorder with Hyperactivity Diseases 0.000 description 1
- 208000008035 Back Pain Diseases 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 206010004053 Bacterial toxaemia Diseases 0.000 description 1
- VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 description 1
- 208000002881 Colic Diseases 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 208000034656 Contusions Diseases 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 206010056340 Diabetic ulcer Diseases 0.000 description 1
- 241000498255 Enterobius vermicularis Species 0.000 description 1
- 208000010201 Exanthema Diseases 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 208000007101 Muscle Cramp Diseases 0.000 description 1
- 208000000112 Myalgia Diseases 0.000 description 1
- 206010028813 Nausea Diseases 0.000 description 1
- 206010028836 Neck pain Diseases 0.000 description 1
- 244000061176 Nicotiana tabacum Species 0.000 description 1
- 235000002637 Nicotiana tabacum Nutrition 0.000 description 1
- 206010068319 Oropharyngeal pain Diseases 0.000 description 1
- 206010034464 Periarthritis Diseases 0.000 description 1
- 201000007100 Pharyngitis Diseases 0.000 description 1
- 235000006040 Prunus persica var persica Nutrition 0.000 description 1
- 206010064127 Solar lentigo Diseases 0.000 description 1
- 208000007536 Thrombosis Diseases 0.000 description 1
- 208000013222 Toxemia Diseases 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 238000001467 acupuncture Methods 0.000 description 1
- 230000001919 adrenal effect Effects 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 208000007502 anemia Diseases 0.000 description 1
- 229910052787 antimony Inorganic materials 0.000 description 1
- WATWJIUSRGPENY-UHFFFAOYSA-N antimony atom Chemical compound [Sb] WATWJIUSRGPENY-UHFFFAOYSA-N 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 208000019804 backache Diseases 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 230000029918 bioluminescence Effects 0.000 description 1
- 238000005415 bioluminescence Methods 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000000133 brain stem Anatomy 0.000 description 1
- 229910052793 cadmium Inorganic materials 0.000 description 1
- BDOSMKKIYDKNTQ-UHFFFAOYSA-N cadmium atom Chemical compound [Cd] BDOSMKKIYDKNTQ-UHFFFAOYSA-N 0.000 description 1
- 210000001638 cerebellum Anatomy 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000002655 chelation therapy Methods 0.000 description 1
- 229910052804 chromium Inorganic materials 0.000 description 1
- 239000011651 chromium Substances 0.000 description 1
- 235000019504 cigarettes Nutrition 0.000 description 1
- 239000010941 cobalt Substances 0.000 description 1
- 229910017052 cobalt Inorganic materials 0.000 description 1
- GUTLYIVDDKVIGB-UHFFFAOYSA-N cobalt atom Chemical compound [Co] GUTLYIVDDKVIGB-UHFFFAOYSA-N 0.000 description 1
- 206010009887 colitis Diseases 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 235000013365 dairy product Nutrition 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- 208000007176 earache Diseases 0.000 description 1
- 230000008451 emotion Effects 0.000 description 1
- 206010014881 enterobiasis Diseases 0.000 description 1
- 231100000317 environmental toxin Toxicity 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- 201000005884 exanthem Diseases 0.000 description 1
- 235000020650 eye health related herbal supplements Nutrition 0.000 description 1
- 201000010603 frozen shoulder Diseases 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 229910001385 heavy metal Inorganic materials 0.000 description 1
- XLYOFNOQVPJJNP-ZSJDYOACSA-N heavy water Substances [2H]O[2H] XLYOFNOQVPJJNP-ZSJDYOACSA-N 0.000 description 1
- 230000002440 hepatic effect Effects 0.000 description 1
- 208000012285 hip pain Diseases 0.000 description 1
- 238000002169 hydrotherapy Methods 0.000 description 1
- 238000002639 hyperbaric oxygen therapy Methods 0.000 description 1
- 208000035231 inattentive type attention deficit hyperactivity disease Diseases 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 210000001503 joint Anatomy 0.000 description 1
- YAFQFNOUYXZVPZ-UHFFFAOYSA-N liproxstatin-1 Chemical compound ClC1=CC=CC(CNC=2C3(CCNCC3)NC3=CC=CC=C3N=2)=C1 YAFQFNOUYXZVPZ-UHFFFAOYSA-N 0.000 description 1
- 210000002540 macrophage Anatomy 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 208000013465 muscle pain Diseases 0.000 description 1
- 230000008693 nausea Effects 0.000 description 1
- 230000003472 neutralizing effect Effects 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 239000012466 permeate Substances 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 235000017924 poor diet Nutrition 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 230000000750 progressive effect Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 208000020016 psychiatric disease Diseases 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 206010037844 rash Diseases 0.000 description 1
- 231100000241 scar Toxicity 0.000 description 1
- 230000037390 scarring Effects 0.000 description 1
- 231100000046 skin rash Toxicity 0.000 description 1
- 230000000391 smoking effect Effects 0.000 description 1
- 210000001562 sternum Anatomy 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 201000009032 substance abuse Diseases 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 229960003604 testosterone Drugs 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 239000012780 transparent material Substances 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 210000003932 urinary bladder Anatomy 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
- 230000037303 wrinkles Effects 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/44—Applying ionised fluids
- A61N1/445—Hydro-electric baths
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N5/067—Radiation therapy using light using laser light
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N2005/0664—Details
- A61N2005/0668—Apparatus adapted for operation in a moist environment, e.g. bath or shower
Definitions
- the present invention relates to a laser ionization therapy system and method capable of efficiently removing toxins from a patient's body.
- Many detoxification techniques and therapies include ascorbic acid flush, blood purification, chelation therapy, exercise, fasting, hyperbaric oxygen therapy, hydrotherapy, juicing, light therapy, acupuncture, acupressure, biofeedback, chiropractic therapy, herbal supplements, massage, meditation, etc., to detoxify, heal, or otherwise remove stress accumulated by the body. Accordingly, many therapies may be difficult, time consuming, unhealthy, and even painful.
- a bioluminescence theory recognizes that DNA replication emits light between 630 and 640 nm and, therefore, light by a He—Ne or ERCHONIATM laser may accelerate DNA replication via photonic stimulation.
- a type of light therapy called cold laser therapy, for example, uses a low intensity beam of laser light capable of stimulating natural healing processes at a cellular level.
- Cold laser therapy has proven effective in the area of chiropractic therapy in reducing pain and swelling, promoting healing processes, in treating old injuries, etc.
- ionization therapy is currently being used to detoxify the body.
- a power supply is connected to an electrode array.
- the electrode array is immersed within a tub of water along with the hands, feet, or whole body of the patient.
- the power supply delivers a low voltage direct current into the electrode array to generate positively and negatively charged ions within the water.
- the generated ions travel through the body and neutralize oppositely charged particles which are then diffused out of the body through dispersion wherever the body contacts the water.
- Ionization therapy often detoxifies the whole body more effectively and faster than any herbal or fasting therapies and results in little or no stress to the patient.
- the present invention is directed to a laser ionization therapy system that substantially obviates one or more of the problems due to limitations and disadvantages of the related art.
- An advantage of the present invention aids in the detoxification of a human body.
- Another advantage of the present invention provides enhanced detoxification techniques using existing equipment having previously been used in diverse therapeutic treatments.
- a detoxification method may, for example, include contacting at least a portion of a therapy subject with water; generating ions within the water for a predetermined period of time; and irradiating the therapy subject with substantially coherent light during the predetermined period of time.
- a detoxification method may, for example, include immersing at least a portion of a patient's body within a reservoir filled with water; generating ions within the water; and simultaneously with the generating ions, irradiating a predetermined area of the therapy subject with laser light.
- FIG. 1 illustrates the laser-ionization therapy system according to the principles of the present invention.
- FIGS. 2A-G illustrate predetermined areas of a patient's body that may be irradiated with light.
- FIG. 1 illustrates the laser-ionization therapy system according to the principles of the present invention.
- the laser-ionization therapy system is capable of relaxing a patient's body at the cellular level to increase the efficiency at which toxins are removed from the body.
- toxins may include toxins from infections, alcohol, drugs, and binders in drugs.
- One application is to help remove drugs related to mental illness so that other drugs may then be used by the patient. Further, it is useful in helping with drug and alcohol rehabilitation.
- the laser-ionization therapy system 100 may generally comprise an ion generating unit 200 and a cold laser unit 300 .
- the ion generating unit 200 comprises a power supply 210 , an electrode array 220 coupled to the power supply 210 , and a reservoir 230 .
- the electrode array 220 may be comprised of slow-corroding, replaceable electrodes mounted within a housing 224 .
- the electrodes within the electrode array 220 may comprise an anode 226 and a cathode 228 .
- the power supply 210 is capable of delivering a low voltage direct current to the electrode array 220 and may further comprise a display screen 212 (e.g., an LED display) capable of displaying the voltage and amperage of a treatment power applied from the power supply 210 to the electrode array 220 .
- the display screen 212 may also be capable of displaying amount of time elapsed during treatment of a patient.
- the power supply 210 may be programmed with at least five ionization treatment options: at least three ionization treatment options may be pre-programmed and at least two ionization treatment options may be custom designed for each patient.
- the custom designed ionization treatment options may be designed based on results of a first muscle testing procedure. Further, the power supply 210 may detect level of conductivity of the ionized water and direct the user to add more water or salt to adjust the conductivity of the ionized water to a desired level.
- a first ionization treatment option may result in the generation of only positive ions within a predetermined treatment time (e.g., about 30 minutes).
- a second ionization treatment option may result in the generation of only negative ions within the predetermined treatment time.
- a third ionization treatment option may result in the generation of a mix of positive and negative ions such that about 70% of the generated ions are positive while about 30% of the generated ions are negative.
- a fourth ionization treatment option may result in the generation of positive ions for about 15 minutes, then negative ions for about 10 minutes, and finally positive ions for about 5 minutes.
- a fifth ionization treatment option may result in the generation of negative ions for about 15 minutes, then positive ions for about 10 minutes, and finally negative ions for about 5 minutes.
- the cold laser unit 300 may, for example, comprise a base unit 310 and a probe 320 coupled to the base unit 310 via an optical cable 330 .
- substantially coherent light e.g., laser light
- the base unit 310 may generate light at a wavelength of substantially between about 630 and about 640 nm and at a power of about 5 Mw or less.
- light generated by the base unit 310 has a wavelength of substantially about 635 nm.
- generated light may be directed toward the patient's body as a substantially continuous beam of light or a pulsed beam having a predetermined frequency.
- pulsing of the light directed toward the patient may alleviate pain and increase circulation within the body, stimulate glands, etc.
- the frequency at which light directed toward the patient is pulsed may determined based on results of a second muscle testing procedure and the location of the patient's body where the light is to be directed.
- the electrode array 220 may be placed in the reservoir 230 and immersed in water 112 contained therein.
- the water 112 may be provided as normal tap water.
- a predetermined amount e.g. a half cup
- mineral salts and/or a predetermined amount e.g., about 1 tsp
- the liquid minerals may include magnesium with 50 types of trace minerals.
- Dead Sea salt While various types may be used, mineralized salt is preferred. Further, Dead Sea salt has been shown to be particularly beneficial. Also, it is beneficial to add essential oils to the salt or to the water to provide additional benefits. The combination of Dead Sea salt and essential oils has lead to approximately a 20% increase in effectiveness. For example the following types of oils may be used: grapefruit, eucalyptus, lavender, bergamot, lemon grass, lime, rosemary, spearmint, sweet orange, chamomile, tea tree, and geranium. Further the following blends of oils can help provide the following benefits:
- the power supply 210 is capable of delivering a low voltage direct current to the electrode array 220 .
- the low voltage direct current has a voltage of about 2.45 Amps. and about 19V.
- water 112 within the reservoir 230 may become oxidized (i.e., 2H 2 O ⁇ O 2 +4H + +4e ⁇ ) at the anode 226 while the water 112 may be reduced (i.e., 4H2O+4e ⁇ ⁇ 2H 2 +4OH ⁇ ) at the cathode 228 .
- the low voltage direct current is positive, the ions generated in the water 112 will generally be negative in polarity.
- the ions generated in the water 112 will generally be positive in polarity.
- the amount and polarity of ions generated within the water may be selectively adjusted.
- the generated ions permeate the patient's body and attach themselves to oppositely charged particles, thereby neutralizing toxins within the body.
- the neutralized toxins are then removed from the patient's body by a process known as dispersion.
- the base unit 310 may be activated such that light may be directed toward predetermined areas of the patient's body using the probe 320 .
- light generated by the base unit 310 may be emitted toward the patient's body during the entire time ions are generated by the ion generating unit 200 .
- the reservoir 230 may be made of a transparent material, electrically insulative, and capable of holding water (e.g., plastic, glass, etc.). Accordingly, the probe 320 may be arranged proximate exterior of the reservoir 230 such that light emitted from the probe 320 is transmitted through the reservoir 230 and water 112 and onto predetermined areas of the patient's body that are in contact with the water 112 . In another aspect of the present invention, the probe may be arranged proximate predetermined areas of the patient's body that are not in contact with the water 112 such that light emitted by the probe 320 directly irradiates the predetermined area of the patient's body.
- the water 112 within the reservoir 230 may turn different colors and consistencies.
- the change in the water is the result of the toxins being extracted from the body as a result of the combined actions of the laser light and the generated ions.
- the water 112 may turn yellow-green when it contains toxins extracted from the patient's kidney, bladder, urinary tract, and the prostate area.
- the water 112 may turn orange when it contains toxins extracted from the patient's joints.
- the water 112 may turn brown when it contains toxins extracted from the patient's liver. Brown colored water also contains tobacco and cellular debris.
- the water 112 may turn black when it contains toxins extracted from the patient's gallbladder and liver.
- the water 112 may turn dark green when it contains toxins extracted from the patient's gallbladder.
- the water 112 may turn white and foamy when it contains mucous extracted from the patient's lymphatic system.
- the water 112 may contain white cheese-like particles, indicating the presence of yeast.
- the water 112 may contain black flecks of material, indicating the presence of heavy metals.
- the 112 may contain red flecks, indicating the presence of blood clot material. In some cases, parasites, pinworms, and pungent purple mucous may form within the water when the patient is on dairy allergy medication.
- the amount of toxins (e.g., analyte) found in water 112 within reservoir 230 prior to performing any detoxification therapy, contains a base amount of toxins.
- water 112 within the reservoir 230 contained approximately three orders of magnitude more toxins than water obtained prior to the treatment.
- water 112 within the reservoir 230 contained roughly double the amount of toxins found in the water after performing the related art therapy.
- the laser-ionization therapy method and system removed roughly double the amount of toxins from the patient's body, as compared with results of the related art therapy, within substantially the same amount of time (about 30 minutes).
- the appropriate mix and polarity of generated ions must be determined for each patient through a first muscle testing procedure.
- the amount and type of ions generated may be based, at least in part, on the pH of the patient's saliva.
- alkaline saliva generally corresponds to a first muscle testing procedure requiring the treatment involve the generation of predominantly positive ions.
- acidic saliva generally corresponds to a first muscle testing procedure requiring the treatment involve the generation of predominantly negative ions.
- the frequency at which light directed toward the predetermined area of the patient's body depends on the location of the predetermined area and a second muscle testing procedure.
- Table 2 lists object of the therapeutic treatment (column A), the corresponding area of body involved with irradiation of the light generated by the base unit 310 (column B), and the corresponding pulse frequency of the light emitted by the probe 320 , in pulses per second (column C).
- light directed is pulsed at a predetermined frequency for different areas of a patient's body.
- FIGS. 2A-2G illustrate meridian points that may be irradiated with light generated by the base unit 310 .
- prelasering Prior to having the patient undergo therapy, it is beneficial to irradiate various points of the body with a laser. This is called prelasering. Such prelasering is beneficial when applied to various meridian points listed above. This causes the body to more effectively release toxins during the therapy.
- the ion generating unit 200 may be embodied as a device commonly known as Ion CleanseTM, manufactured by Stargate International (at 10235 S. Progressive Way, #7, Parker Colo., 80134), the cold laser unit 300 may be embodied as a device commonly known as Erchonia Laser PL4TM, manufactured by Erchonia (at 3960 E. Palm Lane, #9, Mesa, Ariz., 85296), and the liquid minerals may be embodied as liquid minerals commonly known as Thor Liquid Ionic MineralsTM, manufactured by Thor, Inc. (at Ogden, Utah, 84401).
- Ion CleanseTM manufactured by Stargate International
- the cold laser unit 300 may be embodied as a device commonly known as Erchonia Laser PL4TM, manufactured by Erchonia (at 3960 E. Palm Lane, #9, Mesa, Ariz., 85296)
- the liquid minerals may be embodied as liquid minerals commonly known as Thor Liquid Ionic MineralsTM, manufactured by Thor, Inc. (at Ogden
- sore muscles, high blood pressure, swelling in joints, arthritis, sever stress, pain, ADD, ADHD, pain, toxemia, and the like may be alleviated using the system and method described above.
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Public Health (AREA)
- Radiology & Medical Imaging (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Physics & Mathematics (AREA)
- Optics & Photonics (AREA)
- Pathology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Radiation-Therapy Devices (AREA)
- Electron Sources, Ion Sources (AREA)
- Laser Surgery Devices (AREA)
Abstract
A detoxification method includes immersing at least a portion of a patient's body within a reservoir filled with water; generating ions within the water; and simultaneously with the generating ions, irradiating a predetermined area of the therapy subject with light generated by a cold laser. The generated light may be irradiated to the patient as either a continuous beam or a pulsed beam. The ions generated within the water may be positive, negative, or combinations thereof. Further, the light may be irradiated as long as the ions are being generated.
Description
- This application is a continuation-in-part of U.S. patent application Ser. No. 11/150,482 now allowed, which is a continuation of U.S. patent application Ser. No. 10/366,159 filed Feb. 14, 2003, now U.S. Pat. No. 6,913,616 each of which are hereby incorporated by reference in their entirety as if fully set forth herein.
- 1. Field of the Invention
- The present invention relates to a laser ionization therapy system and method capable of efficiently removing toxins from a patient's body.
- 2. Discussion of the Related Art
- Disease, stress, surgeries and other medical procedures, environmental toxins, cigarette smoking, alcohol consumption, improper nutrition, and other major and minor abuses tend to leave the human body leave weak and toxic. Because of poor diets and high stress, the body tends to accumulate and store excessive quantities of waste products such as diacetic, lactic, pyurvic, carbonic, acetic, butyric, and hepatic acids. Acids can attack joints, tissues, muscles, organs, and glands causing minor to major dysfunction. Many detoxification techniques and therapies include ascorbic acid flush, blood purification, chelation therapy, exercise, fasting, hyperbaric oxygen therapy, hydrotherapy, juicing, light therapy, acupuncture, acupressure, biofeedback, chiropractic therapy, herbal supplements, massage, meditation, etc., to detoxify, heal, or otherwise remove stress accumulated by the body. Accordingly, many therapies may be difficult, time consuming, unhealthy, and even painful.
- Light therapy has a proven ability that is founded both in history and in science. As far back as 4000 BC, Rig Veda, the sacred books of India, describe the healing power of the Sun God Sanitar. Throughout the Middle Ages, red light was used to treat small pox where the sick were placed in a room illuminated by dim red light filtered through thick red curtains. The Danish physician and Nobel peach prize winner Niels Ryberg Finsen also employed red light to treat scarring that occurs with small pox. Further, several scientific theories have been proposed in attempts to explain basic physiological events occurring at a cellular level when laser irradiation is applied to the body. A bioluminescence theory recognizes that DNA replication emits light between 630 and 640 nm and, therefore, light by a He—Ne or ERCHONIA™ laser may accelerate DNA replication via photonic stimulation. Today, a type of light therapy called cold laser therapy, for example, uses a low intensity beam of laser light capable of stimulating natural healing processes at a cellular level. Cold laser therapy has proven effective in the area of chiropractic therapy in reducing pain and swelling, promoting healing processes, in treating old injuries, etc.
- In addition to the aforementioned therapies, ionization therapy is currently being used to detoxify the body. Using ionization therapy, a power supply is connected to an electrode array. The electrode array is immersed within a tub of water along with the hands, feet, or whole body of the patient. Next, the power supply delivers a low voltage direct current into the electrode array to generate positively and negatively charged ions within the water. The generated ions travel through the body and neutralize oppositely charged particles which are then diffused out of the body through dispersion wherever the body contacts the water. Ionization therapy often detoxifies the whole body more effectively and faster than any herbal or fasting therapies and results in little or no stress to the patient.
- However effective ionization therapy is, the body still is often not fully relaxed at the cellular level. Therefore, the efficiency with which related art ionization therapy apparatus detoxify the body is not optimized. It was this understanding and recognition of the problems with the related art ionization therapy systems that formed the impetus for the present invention.
- Accordingly, the present invention is directed to a laser ionization therapy system that substantially obviates one or more of the problems due to limitations and disadvantages of the related art.
- An advantage of the present invention aids in the detoxification of a human body.
- Another advantage of the present invention provides enhanced detoxification techniques using existing equipment having previously been used in diverse therapeutic treatments.
- Additional features and advantages of the invention will be set forth in the description which follows, and in part will be apparent from the description, or may be learned by practice of the invention. These and other advantages of the invention will be realized and attained by the structure particularly pointed out in the written description and claims hereof as well as the appended drawings.
- To achieve these and other advantages and in accordance with the purpose of the present invention, as embodied and broadly described, a detoxification method may, for example, include contacting at least a portion of a therapy subject with water; generating ions within the water for a predetermined period of time; and irradiating the therapy subject with substantially coherent light during the predetermined period of time.
- In another aspect of the present invention, a detoxification method may, for example, include immersing at least a portion of a patient's body within a reservoir filled with water; generating ions within the water; and simultaneously with the generating ions, irradiating a predetermined area of the therapy subject with laser light.
- It is to be understood that both the foregoing general description and the following detailed description are exemplary and explanatory and are intended to provide further explanation of the invention as claimed.
- The accompanying drawings, which are included to provide a further understanding of the invention and are incorporated in and constitute a part of this specification, illustrate embodiments of the invention and together with the description serve to explain the principles of the invention.
- In the drawings:
-
FIG. 1 illustrates the laser-ionization therapy system according to the principles of the present invention. -
FIGS. 2A-G illustrate predetermined areas of a patient's body that may be irradiated with light. - Reference will now be made in detail to embodiments of the present invention, examples of which are illustrated in the accompanying drawings.
-
FIG. 1 illustrates the laser-ionization therapy system according to the principles of the present invention. - According to the principles of the present invention, the laser-ionization therapy system is capable of relaxing a patient's body at the cellular level to increase the efficiency at which toxins are removed from the body. Such toxins may include toxins from infections, alcohol, drugs, and binders in drugs. One application is to help remove drugs related to mental illness so that other drugs may then be used by the patient. Further, it is useful in helping with drug and alcohol rehabilitation.
- Referring to
FIG. 1 , the laser-ionization therapy system 100 may generally comprise an ion generatingunit 200 and acold laser unit 300. - In one aspect of the present invention, the
ion generating unit 200 comprises apower supply 210, anelectrode array 220 coupled to thepower supply 210, and areservoir 230. Theelectrode array 220 may be comprised of slow-corroding, replaceable electrodes mounted within ahousing 224. The electrodes within theelectrode array 220 may comprise ananode 226 and acathode 228. Thepower supply 210 is capable of delivering a low voltage direct current to theelectrode array 220 and may further comprise a display screen 212 (e.g., an LED display) capable of displaying the voltage and amperage of a treatment power applied from thepower supply 210 to theelectrode array 220. Thedisplay screen 212 may also be capable of displaying amount of time elapsed during treatment of a patient. - The
power supply 210 may be programmed with at least five ionization treatment options: at least three ionization treatment options may be pre-programmed and at least two ionization treatment options may be custom designed for each patient. In one aspect of the present invention, the custom designed ionization treatment options may be designed based on results of a first muscle testing procedure. Further, thepower supply 210 may detect level of conductivity of the ionized water and direct the user to add more water or salt to adjust the conductivity of the ionized water to a desired level. - In one aspect of the present invention, a first ionization treatment option may result in the generation of only positive ions within a predetermined treatment time (e.g., about 30 minutes). A second ionization treatment option may result in the generation of only negative ions within the predetermined treatment time. A third ionization treatment option may result in the generation of a mix of positive and negative ions such that about 70% of the generated ions are positive while about 30% of the generated ions are negative. A fourth ionization treatment option may result in the generation of positive ions for about 15 minutes, then negative ions for about 10 minutes, and finally positive ions for about 5 minutes. A fifth ionization treatment option may result in the generation of negative ions for about 15 minutes, then positive ions for about 10 minutes, and finally negative ions for about 5 minutes.
- The
cold laser unit 300 may, for example, comprise abase unit 310 and aprobe 320 coupled to thebase unit 310 via anoptical cable 330. According to the principles of the present invention, substantially coherent light (e.g., laser light) may be generated by thebase unit 310 and transmitted to theprobe 320 via theoptical cable 330. Light exiting theprobe 320 may be directed toward predetermined areas of the patient's body. In one aspect of the present invention, thebase unit 310 may generate light at a wavelength of substantially between about 630 and about 640 nm and at a power of about 5 Mw or less. In one aspect of the present invention, light generated by thebase unit 310 has a wavelength of substantially about 635 nm. In one aspect of the present invention, generated light may be directed toward the patient's body as a substantially continuous beam of light or a pulsed beam having a predetermined frequency. In one aspect of the present invention, pulsing of the light directed toward the patient may alleviate pain and increase circulation within the body, stimulate glands, etc. In one aspect of the present invention, the frequency at which light directed toward the patient is pulsed may determined based on results of a second muscle testing procedure and the location of the patient's body where the light is to be directed. - According to the principles of the present invention, the
electrode array 220 may be placed in thereservoir 230 and immersed inwater 112 contained therein. In one aspect of the present invention, thewater 112 may be provided as normal tap water. In another aspect of the present invention, a predetermined amount (e.g. a half cup) mineral salts and/or a predetermined amount (e.g., about 1 tsp) of liquid minerals may be mixed with thewater 112 to enhance the electrical conductivity characteristics of thewater 112. In one aspect of the present invention the liquid minerals may include magnesium with 50 types of trace minerals. - While various types of salts may be used, mineralized salt is preferred. Further, Dead Sea salt has been shown to be particularly beneficial. Also, it is beneficial to add essential oils to the salt or to the water to provide additional benefits. The combination of Dead Sea salt and essential oils has lead to approximately a 20% increase in effectiveness. For example the following types of oils may be used: grapefruit, eucalyptus, lavender, bergamot, lemon grass, lime, rosemary, spearmint, sweet orange, chamomile, tea tree, and geranium. Further the following blends of oils can help provide the following benefits:
-
75% grapefruit and 25% eucalyptus cleansing 50% lavender and 50% bergamot soothing and relaxing 25% lemon grass and 75% lime uplifting 25% rosemary and 75% spearmint energizing 75% sweet orange and 25% chamomile calm and happy 1 oz. of 25% eucalyptus and 75% lavender with cold relief 6 drops tea tree 50% geranium and 50% grapefruit tired and muscle relief.
Other essential oils may also be used. Also, other mixtures of essential oils may be used. The oil can be either added to the water separately or be mixed with the salt. Further, the salt may be in granular form or be in the form of a tablet, with or without the essential oil. - As mentioned above, the
power supply 210 is capable of delivering a low voltage direct current to theelectrode array 220. In one aspect of the present invention, the low voltage direct current has a voltage of about 2.45 Amps. and about 19V. Upon receipt of the low voltage direct current at theelectrode array 220,water 112 within thereservoir 230 may become oxidized (i.e., 2H2O→O2+4H++4e−) at theanode 226 while thewater 112 may be reduced (i.e., 4H2O+4e−→2H2+4OH−) at thecathode 228. When the low voltage direct current is positive, the ions generated in thewater 112 will generally be negative in polarity. Alternatively, when the low voltage direct current is negative, the ions generated in thewater 112 will generally be positive in polarity. By changing the polarity of the low voltage applied to theelectrode array 220, the amount and polarity of ions generated within the water may be selectively adjusted. The generated ions permeate the patient's body and attach themselves to oppositely charged particles, thereby neutralizing toxins within the body. The neutralized toxins are then removed from the patient's body by a process known as dispersion. Substantially simultaneously with the generation of the ions, thebase unit 310 may be activated such that light may be directed toward predetermined areas of the patient's body using theprobe 320. In one aspect of the present invention, light generated by thebase unit 310 may be emitted toward the patient's body during the entire time ions are generated by theion generating unit 200. - In one aspect of the present invention, the
reservoir 230 may be made of a transparent material, electrically insulative, and capable of holding water (e.g., plastic, glass, etc.). Accordingly, theprobe 320 may be arranged proximate exterior of thereservoir 230 such that light emitted from theprobe 320 is transmitted through thereservoir 230 andwater 112 and onto predetermined areas of the patient's body that are in contact with thewater 112. In another aspect of the present invention, the probe may be arranged proximate predetermined areas of the patient's body that are not in contact with thewater 112 such that light emitted by theprobe 320 directly irradiates the predetermined area of the patient's body. - During and after the laser-ionization treatment, the
water 112 within thereservoir 230 may turn different colors and consistencies. The change in the water is the result of the toxins being extracted from the body as a result of the combined actions of the laser light and the generated ions. For example, thewater 112 may turn yellow-green when it contains toxins extracted from the patient's kidney, bladder, urinary tract, and the prostate area. Thewater 112 may turn orange when it contains toxins extracted from the patient's joints. Thewater 112 may turn brown when it contains toxins extracted from the patient's liver. Brown colored water also contains tobacco and cellular debris. Thewater 112 may turn black when it contains toxins extracted from the patient's gallbladder and liver. Thewater 112 may turn dark green when it contains toxins extracted from the patient's gallbladder. Thewater 112 may turn white and foamy when it contains mucous extracted from the patient's lymphatic system. Thewater 112 may contain white cheese-like particles, indicating the presence of yeast. Thewater 112 may contain black flecks of material, indicating the presence of heavy metals. Lastly, the 112 may contain red flecks, indicating the presence of blood clot material. In some cases, parasites, pinworms, and pungent purple mucous may form within the water when the patient is on dairy allergy medication. -
TABLE 1 Laser-Ionization Ion Generating Therapy System Plain Tap Water Unit after 30 mins. after 30 mins. Analyte (ppb) (ppb) (ppb) Antimony <1 <1 <1 Cadmium <0.3 <0.3 <0.3 Chromium 4.6 4000 8400 Cobalt <10 38 63 Iron 20 19,000 40,000 - As shown above in Table 1, the amount of toxins (e.g., analyte) found in
water 112 withinreservoir 230, prior to performing any detoxification therapy, contains a base amount of toxins. After performing related art detoxification treatments, such as those including only the activation of devices similar to theion generation unit 200 for about 30 minutes,water 112 within thereservoir 230 contained approximately three orders of magnitude more toxins than water obtained prior to the treatment. However, after performing the laser-ionization therapy in accordance with the principles of the present invention,water 112 within thereservoir 230 contained roughly double the amount of toxins found in the water after performing the related art therapy. Further, the laser-ionization therapy method and system removed roughly double the amount of toxins from the patient's body, as compared with results of the related art therapy, within substantially the same amount of time (about 30 minutes). - In one aspect of the present invention, and as already mentioned above, the appropriate mix and polarity of generated ions must be determined for each patient through a first muscle testing procedure. Further, the amount and type of ions generated may be based, at least in part, on the pH of the patient's saliva. For example, alkaline saliva generally corresponds to a first muscle testing procedure requiring the treatment involve the generation of predominantly positive ions. Alternatively, acidic saliva generally corresponds to a first muscle testing procedure requiring the treatment involve the generation of predominantly negative ions.
- Also as mentioned above, the frequency at which light directed toward the predetermined area of the patient's body depends on the location of the predetermined area and a second muscle testing procedure. Below, Table 2 lists object of the therapeutic treatment (column A), the corresponding area of body involved with irradiation of the light generated by the base unit 310 (column B), and the corresponding pulse frequency of the light emitted by the
probe 320, in pulses per second (column C). Depending upon the results of the second muscle testing procedure, light directed is pulsed at a predetermined frequency for different areas of a patient's body. Further,FIGS. 2A-2G illustrate meridian points that may be irradiated with light generated by thebase unit 310. -
TABLE 2 A B C Allergies Lungs, Sinus 1, 2, 4, 120, 213, 273, 500 Adrenal AOI (area of involvement) 21, 24 Anemia Navel, Spleen, Sternum 2, 10, 50, 260 Arthritis AOI 10, 20, 25, 48, 50 Asthma Lungs, T-1 to T-4 2. 41, 120, 213, 273 Backache AOI 5, 6, 7, 72, 100 Bacteria AOI, Thymus, Spleen 1, 3, 5, 6, 83, 100, 187, 351 Bacterial Virus AOI 6, 84 Bowel Flora AOI, Bowel 2, 21, 24, 250 Brain Brain, Cerebellum 8, 13, 15, 33, 37, 60, 61 Brain Stem Brain Stem 2, 210 Bruises AOI 5, 10, 12, 50 Burns AOI, Lymphatics 10, 17, 20, 25, 30, 50 Circulation AOI 8, 11, 16, 31, 46, 633 Prostate Prostate 15, 16, 31, 33 Red Blood Cells AOI 11, 45 Scar Tissue AOI 18, 20, 25, 279 Sinuses AOI 2, 4, 6, 86, 120, 323 Skin Rash AOI, Liver 1, 363 Sore Throat AOI 5, 9, 12, 42, 53, 91 Stroke AOI, Brain 2, 310 Testosterone AOI 4, 141 Thymus Thymus 3, 11, 20, 25, 45, 153 Ulcers AOI, Nerve Root 4, 22, 23, 133 Warts AOI, Liver 10, 52 Wrinkles AOI 1, 363 Yeast AOI, Yeast Point 6, 12, 41, 77 Colic & Colitis AOI, T-5, L-5 200 Constipation G.I. T-8 to Sacrum 1, 3, 17, 19, 26, 29, 200, 343 Cramps G.I. T-10 to L-5 1, 9, 10, 50, 53, 373 Depression Brain 3, 14, 37, 180 Diabetic Ulcers AOI, Nerve Root 1, 22, 23, 633 Earaches AOI, Lymphatics 5, 100 Eczema AOI, Liver 1, 2, 15, 33, 339, 353 Emotion AOI, Organ 16, 31 Fractures, Bones AOI, Nerve Root 8, 9, 11, 15, 20, 25, 33, 45, 65, 562 Frozen Shoulder AOI, Nerve Root 5, 9, 10, 13, 40, 50, 56, 107 Fungus AOI 9, 53 Gallbladder Gallbladder 1, 9, 13, 38, 55, 458 Gums AOI 5, 6, 83, 104 Hearts Heart 8, 15, 33, 60 Hip Pain Hip, Nerve Root 7, 9, 56, 75 Inflammation AOI, Lymphatics 2, 20, 25, 300 Kidney Kidney 1, 12, 43, 430 Liver Liver 9, 53 Liver Spots AOI, Liver 13, 38 Lymes AOI, Thymus, Liver, Kidney 2, 242, 327, 654, 655, 763, 764 Lymphatics Lymphatic system 2, 4, 12, 20, 25, 42, 139, 300 Macrophages AOI 6, 84 Muscle Pain AOI, Nerve Root 2, 9, 12, 42, 56, 313 Nausea Stomach, Over Lip 1, 12, 14, 37, 42, 825 Neck Pain AOI 9, 10, 13, 40, 50, 56 Nerve AOI, Nerve Root 1, 8, 60, 61, 338, 463 Pain AOI, Nerve Root, Brain 2, 9, 10, 12, 13, 15, 40, 42, 50, 56, 313 Parasites AOI 3, 5, 6, 7, 10, 50, 71, 83, 100, 167, 650, 655, 764, 769 - Prior to having the patient undergo therapy, it is beneficial to irradiate various points of the body with a laser. This is called prelasering. Such prelasering is beneficial when applied to various meridian points listed above. This causes the body to more effectively release toxins during the therapy.
- In accordance with the principles and results of the present invention, there are many possible devices to implement the present invention. As an example, the
ion generating unit 200 may be embodied as a device commonly known as Ion Cleanse™, manufactured by Stargate International (at 10235 S. Progressive Way, #7, Parker Colo., 80134), thecold laser unit 300 may be embodied as a device commonly known as Erchonia Laser PL4™, manufactured by Erchonia (at 3960 E. Palm Lane, #9, Mesa, Ariz., 85296), and the liquid minerals may be embodied as liquid minerals commonly known as Thor Liquid Ionic Minerals™, manufactured by Thor, Inc. (at Ogden, Utah, 84401). - In accordance with the principles of the present invention, sore muscles, high blood pressure, swelling in joints, arthritis, sever stress, pain, ADD, ADHD, pain, toxemia, and the like may be alleviated using the system and method described above.
- It will be apparent to those skilled in the art that various modifications and variation can be made in the present invention without departing from the spirit or scope of the invention. Thus, it is intended that the present invention cover the modifications and variations of this invention provided they come within the scope of the appended claims and their equivalents.
Claims (20)
1. A detoxification method, comprising:
irradiating at least one meridian point of a therapy subjects body with substantially coherent light;
contacting at least a portion of the therapy subject with water after irradiating at least one meridian point of the therapy subjects body;
generating ions within the water for a predetermined period of time; and
irradiating the therapy subject with substantially coherent light during the predetermined period of time.
2. The detoxification method according to claim 1 , wherein a wavelength of the substantially coherent light is between about 630 nm and 640 nm.
3. The detoxification method according to claim 3 , wherein the wavelength of the substantially coherent light is about 635 nm.
4. The detoxification method according to claim 1 , wherein a power of the substantially coherent light is up to about 5 mW.
5. The detoxification method according to claim 1 , further including adding salt to the water.
6. The detoxification method according to claim 1 , wherein the salt is mineralized salt.
7. The detoxification method according to claim 1 , wherein the salt is Dead Sea salt.
8. The detoxification method according to claim 5 , further including adding essential oils to the water.
9. The detoxification method according to claim 8 , wherein the essential oil is one of grapefruit, eucalyptus, lavender, bergamot, lemon grass, lime, rosemary, spearmint, sweet orange, chamomile, tea tree, and geranium.
10. The detoxification method according to claim 8 , wherein a combination of essential oils is added to the water.
11. The detoxification method according to claim 5 , wherein the salt includes an essential oil.
12. The detoxification method according to claim 11 , wherein the salt and essential oil are combined in a tablet.
13. A detoxification method, comprising:
adding salt to some water;
contacting at least a portion of the therapy subject with the water after irradiating at least on point of the therapy subjects body;
generating ions within the water for a predetermined period of time; and
irradiating the therapy subject with substantially coherent light during the predetermined period of time.
14. The detoxification method according to claim 13 , wherein the salt is mineralized salt.
15. The detoxification method according to claim 13 , wherein the salt is Dead Sea salt.
16. The detoxification method according to claim 15 , further including adding essential oils to the water.
17. The detoxification method according to claim 16 , wherein the essential oil is one of grapefruit, eucalyptus, lavender, bergamot, lemon grass, lime, rosemary, spearmint, sweet orange, chamomile, tea tree, and geranium.
18. The detoxification method according to claim 16 , wherein a combination of essential oils is added to the water.
19. The detoxification method according to claim 13 , wherein the salt includes an essential oil.
20. The detoxification method according to claim 19 , wherein the salt and essential oil are combined in a tablet.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US12/292,966 US20090210036A1 (en) | 2003-02-14 | 2008-12-01 | Laser ionization therapy system and method |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US10/366,459 US6913616B2 (en) | 2003-02-14 | 2003-02-14 | Laser ionization therapy system and method |
| US11/150,482 US7458983B2 (en) | 2003-02-14 | 2005-06-13 | Laser ionization therapy system and method |
| US12/292,966 US20090210036A1 (en) | 2003-02-14 | 2008-12-01 | Laser ionization therapy system and method |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| US11/150,482 Continuation US7458983B2 (en) | 2003-02-14 | 2005-06-13 | Laser ionization therapy system and method |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| US20090210036A1 true US20090210036A1 (en) | 2009-08-20 |
Family
ID=32849756
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| US10/366,459 Expired - Lifetime US6913616B2 (en) | 2003-02-14 | 2003-02-14 | Laser ionization therapy system and method |
| US11/150,482 Expired - Lifetime US7458983B2 (en) | 2003-02-14 | 2005-06-13 | Laser ionization therapy system and method |
| US12/292,966 Abandoned US20090210036A1 (en) | 2003-02-14 | 2008-12-01 | Laser ionization therapy system and method |
Family Applications Before (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| US10/366,459 Expired - Lifetime US6913616B2 (en) | 2003-02-14 | 2003-02-14 | Laser ionization therapy system and method |
| US11/150,482 Expired - Lifetime US7458983B2 (en) | 2003-02-14 | 2005-06-13 | Laser ionization therapy system and method |
Country Status (10)
| Country | Link |
|---|---|
| US (3) | US6913616B2 (en) |
| EP (1) | EP1596927A4 (en) |
| JP (1) | JP4718441B2 (en) |
| KR (1) | KR20050120751A (en) |
| CN (1) | CN1832774B (en) |
| AU (1) | AU2004212951B2 (en) |
| CA (1) | CA2516173C (en) |
| MX (1) | MXPA05008689A (en) |
| NZ (1) | NZ541819A (en) |
| WO (1) | WO2004073786A2 (en) |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10589120B1 (en) | 2012-12-31 | 2020-03-17 | Gary John Bellinger | High-intensity laser therapy method and apparatus |
| IT202100024164A1 (en) * | 2021-09-21 | 2023-03-21 | Themis S R L S | DEVICE FOR THE TREATMENT AND CARE OF THE SKIN, OF WOUNDS, TRAUMAS, JOINT PAIN AND/OR POST-TRAUMATIC THROUGH LED THERAPY WITH ACTIVATED WATER |
| IT202100024167A1 (en) * | 2021-09-21 | 2023-03-21 | Themis S R L S | DEVICE FOR THE TREATMENT AND CARE OF SKIN, WOUNDS, TRAUMAS, JOINT PAIN AND/OR POST-TRAUMATIC THROUGH LED THERAPY WITH MAGNETIZED ACTIVATED WATER AND OXYGEN |
| US20250339708A1 (en) * | 2015-10-27 | 2025-11-06 | James Steve Hamilton | Laser ionization therapy assembly and oil-infused bath salt compositions for use therewith |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20040226556A1 (en) | 2003-05-13 | 2004-11-18 | Deem Mark E. | Apparatus for treating asthma using neurotoxin |
| US8041428B2 (en) | 2006-02-10 | 2011-10-18 | Electrocore Llc | Electrical stimulation treatment of hypotension |
| US9037247B2 (en) | 2005-11-10 | 2015-05-19 | ElectroCore, LLC | Non-invasive treatment of bronchial constriction |
| US7747324B2 (en) | 2005-11-10 | 2010-06-29 | Electrocore Llc | Electrical stimulation treatment of bronchial constriction |
| US8812112B2 (en) | 2005-11-10 | 2014-08-19 | ElectroCore, LLC | Electrical treatment of bronchial constriction |
| CN101400403A (en) | 2006-02-10 | 2009-04-01 | 电子核心公司 | Methods and apparatus for treating anaphylaxis using electrical modulation |
| JP2009525806A (en) * | 2006-02-10 | 2009-07-16 | エレクトロコア、インコーポレイテッド | Electrical stimulation treatment for hypotension |
| US8483831B1 (en) | 2008-02-15 | 2013-07-09 | Holaira, Inc. | System and method for bronchial dilation |
| US8088127B2 (en) | 2008-05-09 | 2012-01-03 | Innovative Pulmonary Solutions, Inc. | Systems, assemblies, and methods for treating a bronchial tree |
| EP2493408B1 (en) | 2009-10-27 | 2015-06-24 | Holaira, Inc. | Delivery devices with coolable energy emitting assemblies |
| US9149328B2 (en) | 2009-11-11 | 2015-10-06 | Holaira, Inc. | Systems, apparatuses, and methods for treating tissue and controlling stenosis |
| US8911439B2 (en) | 2009-11-11 | 2014-12-16 | Holaira, Inc. | Non-invasive and minimally invasive denervation methods and systems for performing the same |
| RU2519725C2 (en) * | 2012-09-26 | 2014-06-20 | Андрей Васильевич Голубцов | Method of assessment of action on animal organism of low intensity laser irradiation of blood |
| US9398933B2 (en) | 2012-12-27 | 2016-07-26 | Holaira, Inc. | Methods for improving drug efficacy including a combination of drug administration and nerve modulation |
| CN105574316B (en) * | 2014-10-17 | 2018-08-21 | 秦军 | A kind of hyperbaric oxygen quality control informationization management system based on Internet of Things |
| US10602957B2 (en) | 2015-06-30 | 2020-03-31 | Varuna Biomedical Corporation | Systems and methods for detecting and visualizing biofields with nuclear magnetic resonance imaging and QED quantum coherent fluid immersion |
| JP2020510460A (en) * | 2017-01-12 | 2020-04-09 | バルナ バイオメディカル コーポレーションVaruna Biomedical Corporation | Systems and methods for biomodulation using fluid immersion paths and light-induced coherent resonant energy transfer |
Citations (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4943432A (en) * | 1985-10-08 | 1990-07-24 | Biener Hans F | Salt mixture for the treatment of psoriasis |
| US4945908A (en) * | 1985-11-07 | 1990-08-07 | Karl Schneider | Balneo-phototherapeutical treatment process and bath |
| US5259380A (en) * | 1987-11-04 | 1993-11-09 | Amcor Electronics, Ltd. | Light therapy system |
| US5948439A (en) * | 1997-10-31 | 1999-09-07 | Farmo-Nat Ltd. | Effervescent granules |
| US6500197B1 (en) * | 1999-01-28 | 2002-12-31 | Vitasalin Ag | Full-body atomised bath and method for providing a full body atomised bath |
| US6752517B2 (en) * | 2002-02-06 | 2004-06-22 | Kohler Co. | Bathtub chromatherapy system |
| US20050203585A1 (en) * | 2004-02-19 | 2005-09-15 | Best Health Products, Inc. | Water electrode |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CH120933A (en) * | 1926-06-23 | 1927-06-16 | Bauer Adolf | Bathtub for cataphoresis baths. |
| FR2255922A1 (en) * | 1973-12-28 | 1975-07-25 | Sirretta Raymond | Electrical therapy and acupuncture treatment unit - has electrode and body in bath compartments with partition passing ions |
| US4438498A (en) * | 1981-07-13 | 1984-03-20 | Tektronix, Inc. | Power supply output monitoring method and apparatus |
| US4696721A (en) * | 1985-12-27 | 1987-09-29 | Kabushiki Kaisha Toshiba | Electroforming method and electroforming apparatus |
| JPS6363474A (en) * | 1986-09-03 | 1988-03-19 | 古形 勝 | Ion ball |
| US5514168A (en) * | 1994-05-20 | 1996-05-07 | Friedman; Mark H. | Treatment of vascular headache and atypical facial pain |
| US6280591B1 (en) * | 1997-10-01 | 2001-08-28 | Fuji Xerox Co., Ltd. | Image forming method and image forming material |
| FR2773062B1 (en) * | 1997-12-31 | 2000-04-21 | Serge Burdino | INSTALLATION FOR TREATING A LIVING ORGANISM BY IONIZATION |
| WO2000063736A2 (en) * | 1999-04-19 | 2000-10-26 | Imperial College Innovations Limited | Optical microscopy and its use in the study of cells |
| US20030002297A1 (en) * | 2001-06-26 | 2003-01-02 | Nemtsev Igor Z. | Light bracelet and brace |
| US6807874B2 (en) * | 2002-01-21 | 2004-10-26 | Shimadzu Corporation | Collecting apparatus of floating dusts in atmosphere |
-
2003
- 2003-02-14 US US10/366,459 patent/US6913616B2/en not_active Expired - Lifetime
-
2004
- 2004-02-13 NZ NZ541819A patent/NZ541819A/en not_active IP Right Cessation
- 2004-02-13 CA CA2516173A patent/CA2516173C/en not_active Expired - Lifetime
- 2004-02-13 AU AU2004212951A patent/AU2004212951B2/en not_active Ceased
- 2004-02-13 CN CN2004800068846A patent/CN1832774B/en not_active Expired - Fee Related
- 2004-02-13 JP JP2006503577A patent/JP4718441B2/en not_active Expired - Fee Related
- 2004-02-13 WO PCT/US2004/004363 patent/WO2004073786A2/en not_active Ceased
- 2004-02-13 MX MXPA05008689A patent/MXPA05008689A/en active IP Right Grant
- 2004-02-13 KR KR1020057015067A patent/KR20050120751A/en not_active Ceased
- 2004-02-13 EP EP04711222A patent/EP1596927A4/en not_active Withdrawn
-
2005
- 2005-06-13 US US11/150,482 patent/US7458983B2/en not_active Expired - Lifetime
-
2008
- 2008-12-01 US US12/292,966 patent/US20090210036A1/en not_active Abandoned
Patent Citations (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4943432A (en) * | 1985-10-08 | 1990-07-24 | Biener Hans F | Salt mixture for the treatment of psoriasis |
| US4945908A (en) * | 1985-11-07 | 1990-08-07 | Karl Schneider | Balneo-phototherapeutical treatment process and bath |
| US5259380A (en) * | 1987-11-04 | 1993-11-09 | Amcor Electronics, Ltd. | Light therapy system |
| US5948439A (en) * | 1997-10-31 | 1999-09-07 | Farmo-Nat Ltd. | Effervescent granules |
| US6500197B1 (en) * | 1999-01-28 | 2002-12-31 | Vitasalin Ag | Full-body atomised bath and method for providing a full body atomised bath |
| US6752517B2 (en) * | 2002-02-06 | 2004-06-22 | Kohler Co. | Bathtub chromatherapy system |
| US20050203585A1 (en) * | 2004-02-19 | 2005-09-15 | Best Health Products, Inc. | Water electrode |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10589120B1 (en) | 2012-12-31 | 2020-03-17 | Gary John Bellinger | High-intensity laser therapy method and apparatus |
| US20250339708A1 (en) * | 2015-10-27 | 2025-11-06 | James Steve Hamilton | Laser ionization therapy assembly and oil-infused bath salt compositions for use therewith |
| IT202100024164A1 (en) * | 2021-09-21 | 2023-03-21 | Themis S R L S | DEVICE FOR THE TREATMENT AND CARE OF THE SKIN, OF WOUNDS, TRAUMAS, JOINT PAIN AND/OR POST-TRAUMATIC THROUGH LED THERAPY WITH ACTIVATED WATER |
| IT202100024167A1 (en) * | 2021-09-21 | 2023-03-21 | Themis S R L S | DEVICE FOR THE TREATMENT AND CARE OF SKIN, WOUNDS, TRAUMAS, JOINT PAIN AND/OR POST-TRAUMATIC THROUGH LED THERAPY WITH MAGNETIZED ACTIVATED WATER AND OXYGEN |
Also Published As
| Publication number | Publication date |
|---|---|
| US7458983B2 (en) | 2008-12-02 |
| KR20050120751A (en) | 2005-12-23 |
| WO2004073786A8 (en) | 2007-02-01 |
| MXPA05008689A (en) | 2006-05-22 |
| JP4718441B2 (en) | 2011-07-06 |
| EP1596927A2 (en) | 2005-11-23 |
| NZ541819A (en) | 2008-02-29 |
| WO2004073786A3 (en) | 2005-04-21 |
| AU2004212951B2 (en) | 2006-10-12 |
| US6913616B2 (en) | 2005-07-05 |
| CN1832774B (en) | 2011-03-02 |
| WO2004073786A2 (en) | 2004-09-02 |
| US20060015158A1 (en) | 2006-01-19 |
| CA2516173A1 (en) | 2004-09-02 |
| AU2004212951A1 (en) | 2004-09-02 |
| EP1596927A4 (en) | 2010-10-06 |
| CN1832774A (en) | 2006-09-13 |
| JP2006517845A (en) | 2006-08-03 |
| CA2516173C (en) | 2014-11-04 |
| US20040162597A1 (en) | 2004-08-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20090210036A1 (en) | Laser ionization therapy system and method | |
| CN1081096A (en) | Manual acupressure massage therapeutic instrument | |
| CN202036701U (en) | L-shaped double-end laser jade magnetic oxygen pulse moxibustion instrument | |
| Gordon et al. | Sodium salicylate iontophoresis in the treatment of plantar warts | |
| RU2165776C1 (en) | Method for treating glossalgia | |
| AU2007200107B2 (en) | Laser ionization therapy system and method | |
| RU2714457C1 (en) | Method of treating dystrophic spinal and joint diseases | |
| Pawluk | Pain management with pulsed electromagnetic field (PEMF) treatment | |
| RU2285550C2 (en) | Method for reducing abstinence syndrome in opium addiction patients | |
| CN101496931A (en) | Low-potential negative ion health-care physical therapy method and system | |
| RU2278673C1 (en) | Method for treating the cases of locomotor apparatus diseases | |
| US7761149B2 (en) | Electrical stimulus allergy treatment method | |
| HK1095774A (en) | Laser ionization therapy system and method | |
| RU2146953C1 (en) | Method of treatment of chronic prostatitis and increase of potency by electric stimulation | |
| RU2199353C2 (en) | Method for treating the cases of chronic prostatitis | |
| RU2123364C1 (en) | Method for treatment of inflammatory processes and device intended for its realization | |
| RU2271234C1 (en) | Method for treating chronic prostatitis | |
| RU2371217C2 (en) | Method of treatment of chronic prostatitis with sexual function malfunction | |
| Rossen | Introduction to Microcurrent and Guide to Its Greatest Effectiveness | |
| RU2485983C2 (en) | Method for recovering sensor-motor function of central nervous system and peripheral nerves | |
| Gottschalk | Practical electro-therapeutics | |
| CN101015722A (en) | Biological negative electricity channels-collaterals acupoint health care therapeutic method and system | |
| RU98123365A (en) | METHOD FOR TREATING PATIENTS | |
| RU2334528C2 (en) | Method for treatment of chronic prostatitis with sexual dysfunction | |
| Gottschalk | Static electricity, x-ray and electro-vibration |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION |